Rilpivirine
NDC 70069-848, Rilpivirine, tablet, film coated, from Somerset Therapeutics, LLC.
- Product NDC
- 70069-848
- Status
- Listed
- Labeler
- Somerset Therapeutics, LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218798
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70069-848 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RILPIVIRINE HYDROCHLORIDE25 mg/1
Pharmacologic classes
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70069-848-30 | 70069084830 | 30 TABLET, FILM COATED in 1 BOTTLE (70069-848-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fb109de9-d88d-4405-8dd6-d458cbc387d1
Use it
Look up 70069-848 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70069-848 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70069-848. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.